InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.48
(
-0.41%
)
US TECH 100
19,181.60
(
-0.43%
)
Dow Jones
39,118.86
(
-0.12%
)
Brent Oil
84.85
(
0.00%
)
Bitcoin
61,460.29
(
0.93%
)
Post# of 252431
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 832
Posts 119956
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: RNsidersbuying post# 214972

Wednesday, 11/08/2017 6:55:01 PM

Wednesday, November 08, 2017 6:55:01 PM

Post# of 252431

OTIC—these new trial results were "conducted in Europe". How does that play into an upcoming FDA meeting in Q1/18?

If I were long, I’d be concerned not that the ADVERTS-2 trial sites were in Europe, but rather that: 1) ADVERTS-1 (the other phase-3) clearly failed; and 2) ADVERTS-2 was supposedly suspended by the company on 8/30/17 (when the ADVERTS-1 data were reported).

It would be unusual for the FDA to approve a drug where one phase-3 clearly failed and the other phase-3 involved some kind of hanky-panky.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up